Literature DB >> 20872561

Immunoenzymatic assay for the diagnosis of American tegumentary leishmaniasis using soluble and membrane-enriched fractions from infectious Leishmania (Viannia) braziliensis.

Jamyra Iglesias Cataldo1, Fernanda Carvalho de Queiroz Mello, Eliame Mouta-Confort, Maria de Fátima Madeira, Armando de Oliveira Schubach, Marcelo da Silva Genestra, Flávia Coelho Ribeiro, Célia de Fátima Moreira-Venâncio, Sônia Regina Lambert Passos.   

Abstract

The diagnosis of American tegumentary leishmaniasis (ATL) is based on the visualization or isolation of the parasite, which is a time-consuming and poorly sensitive method. In this study, we evaluated the accuracy and reliability of ELISA for the diagnosis of ATL using soluble (SF) and membrane-enriched (MF) antigen fractions obtained from an infectious strain of Leishmania (Viannia) braziliensis. A total of 152 serum samples investigated at a referral center in Rio de Janeiro, Brazil, between 2005 and 2007 were studied. Each sample was tested twice with each fraction for the calculation of reliability (intraclass coefficient (ICC)). Cut-off values of 0.22 (SF) and 0.33 (MF) were defined. The use of the fractions resulted in good discrimination between patients, with a large area under the curve (P<0.0001), but no difference was observed between the two fractions (P=0.45). Sensitivity was 89.5% for each fraction, specificity was 89.5% for SF and 93.4% for MF, and the positive likelihood ratio was 8.5 for SF and 13.6 for MF. The ICCs were excellent (SF: 0.96 and MF: 0.90). The antigens tested provided precision and accuracy for the diagnosis of ATL, with SF being recommended due to its lower cost and greater practicality. J. Clin. Lab. Anal. 24:289-294, 2010.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872561      PMCID: PMC6647712          DOI: 10.1002/jcla.20402

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  24 in total

1.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer
Journal:  Clin Chem       Date:  2003-01       Impact factor: 8.327

Review 2.  The structure and function of the surface lipophosphoglycan on different developmental stages of Leishmania promastigotes.

Authors:  D L Sacks
Journal:  Infect Agents Dis       Date:  1992-08

3.  Sensitivity of an immunoenzymatic test for detection of anti-L. brasiliensis antibodies compared to other tests used for the diagnosis of American cutaneous leishmaniasis.

Authors:  Maíra Peres Ferreira; Ana Maria Ferreira Roselino; Margarida Maria Passeri Nascimento; Juliana Machado Aires; José Fernando de Castro Figueiredo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2006 Jul-Aug       Impact factor: 1.846

4.  Leishmania amazonensis: long-term cultivation of axenic amastigotes is associated to metacyclogenesis of promastigotes.

Authors:  L Cysne-Finkelstein; R M Temporal; F A Alves; L L Leon
Journal:  Exp Parasitol       Date:  1998-05       Impact factor: 2.011

5.  Enzyme immunoassays for parasitic diseases.

Authors:  A Bartlett; D E Bidwell
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

6.  Leishmania major: molecular cloning, sequencing, and expression of the heat shock protein 60 gene reveals unique carboxy terminal peptide sequences.

Authors:  J A Rey-Ladino; P B Joshi; B Singh; R Gupta; N E Reiner
Journal:  Exp Parasitol       Date:  1997-03       Impact factor: 2.011

7.  Antibody subclass profile against Leishmania braziliensis and Leishmania amazonensis in the diagnosis and follow-up of mucosal leishmaniasis.

Authors:  Mariana Junqueira Pedras; Marcela Orsini; Marcelo Castro; Valéria M A Passos; Ana Rabello
Journal:  Diagn Microbiol Infect Dis       Date:  2003-11       Impact factor: 2.803

8.  Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000-dalton surface antigen.

Authors:  M Kweider; J L Lemesre; F Darcy; J P Kusnierz; A Capron; F Santoro
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

9.  Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera.

Authors:  S G Reed; R Badaro; R M Lloyd
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

10.  Serological reactivity of different antigenic preparations of Leishmania (Leishmania) amazonensis and the Leishmania braziliensis complex.

Authors:  Adriano Gomes-Silva; Maria Aparecida Souza; Sandra Regina Afonso-Cardoso; Lívia Resende Andrade; Reynaldo Dietze; Elenice Lemos; Alejandro Belli; Silvio Favoreto Júnior; Marcelo Simão Ferreira
Journal:  Rev Soc Bras Med Trop       Date:  2008 Mar-Apr       Impact factor: 1.581

View more
  5 in total

1.  Sporotrichoid leishmaniasis: a cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro State, Brazil.

Authors:  Livia Martins Veloso de Carvalho; Maria Inês Fernandes Pimentel; Fátima Conceição-Silva; Érica de Camargo Ferreira E Vasconcellos; Cláudia Maria Valete-Rosalino; Marcelo Rosandiski Lyra; Mariza de Matos Salgueiro; Maurício Naoto Saheki; Maria de Fátima Madeira; Eliame Mouta-Confort; Liliane de Fátima Antonio; Aline Fagundes da Silva; Leonardo Pereira Quintella; Sandro Javier Bedoya-Pacheco; Armando de Oliveira Schubach
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-06-01       Impact factor: 1.846

2.  Diagnostic accuracy of Enzyme-Linked Immunosorbent Assays to detect anti-Leishmania antibodies in patients with American Tegumentary Leishmaniasis: a systematic review.

Authors:  Andernice Dos Santos Zanetti; Camila Massae Sato; Fabiana Gulin Longhi; Silvana Margarida Benevides Ferreira; Omar Ariel Espinosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-08-19       Impact factor: 1.846

3.  Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments.

Authors:  José A O'Daly; Humberto M Spinetti; Joe Gleason; María B Rodríguez
Journal:  J Parasitol Res       Date:  2013-06-13

4.  Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins.

Authors:  Ana Paula Souza; Manuel Soto; Jackson M L Costa; Viviane S Boaventura; Camila I de Oliveira; Juqueline R Cristal; Manoel Barral-Netto; Aldina Barral
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

5.  Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance.

Authors:  Killarney Ataide Soares; Ada Amália Ayala Urdapilleta; Gilcilene Maria dos Santos; Andréa Lisboa Carneiro; Ciro Martins Gomes; Ana Maria Roselino; Raimunda Nonata Ribeiro Sampaio
Journal:  Braz J Infect Dis       Date:  2015-05-15       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.